Viewing Study NCT03779867


Ignite Creation Date: 2025-12-25 @ 12:54 AM
Ignite Modification Date: 2026-01-01 @ 9:30 AM
Study NCT ID: NCT03779867
Status: TERMINATED
Last Update Posted: 2025-01-23
First Post: 2018-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Acute Exercise Intervention in Breast Cancer Survivors
Sponsor: Fred Hutchinson Cancer Center
Organization:

Study Overview

Official Title: Acute Effects of Exercise on Breast Cancer Biomarkers (ACE) Study
Status: TERMINATED
Status Verified Date: 2025-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Study closed per SRC low accrual policy.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ACE
Brief Summary: This trial studies how a 45-minute bout of acute exercise in women with a history of breast cancer can affect factors associated with breast cancer and help doctors learn more about how exercise can help prevent breast cancer.

In an earlier part of the study, investigators looked at the effects of the same intervention in women without a history of cancer.
Detailed Description: OUTLINE: Participants are randomized to 1 of 2 arms.

ARM I: Participants undergo a moderate-intensity acute exercise bout over 45 minutes.

ARM II: Participants rest by sitting for 45 minutes.

EXTENSION: After completion of initial study recruitment and data collection, an extension was approved in 2023.

EXTENSION OUTLINE: Participants are randomized to 1 of 2 arms.

EXTENSION ARM I: Participants exercise on a stationary bike for 45 minutes.

EXTENSION ARM II: Participants rest by sitting for 45 minutes.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
8766 OTHER Fred Hutch/University of Washington Cancer Consortium View
NCI-2018-02831 REGISTRY CTRP (Clinical Trial Reporting Program) View